With me today are John Pagliuca, N-able, Inc.'s President and CEO, and Timothy James O’Brien, EVP and CFO. This call is being ...

The Nasdaq 100 dominates market focus, with asset flows and leverage driving outsized gains. Click here for more information ...

A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. Business.com earns commissions from some listed providers. Editorial Guidelines.

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...

Whether you’re skiing in sunny or stormy conditions, we tested and found the best ski jackets including Patagonia, Arc'teryx, ...

This week Gear Break features a 3D printed helmet, pedals with lights, a new bike from Wilier, winter bibs from Castelli, and ...

Featuring: Guided by Voices, Lankum, Sleaford Modes, US Girls, The Besnard Lakes, The Belair Lip Bombs, Depeche Mode, Soulwax ...

Critical analyses of AI usually adopt a stance of defensive humanism. Instead, Nan Da interrogates its mode of reasoning. How ...